Some individuals may experience temporary appetite increases or mild blood sugar dips
This framework also explains something clinicians have observed but struggled to articulate: why GLP-1 medications seem to help patients with conditions that have no obvious connection to obesity
Lipopolysaccharide binds pattern-recognition receptors such as TLR4, triggers innate immune signaling, and releases inflammatory mediators including TNF-alpha
Bioavailability of phytochemicals and its enhancement by drug delivery systems
Bispecific molecules are more often designed to target antigens expressed on the same cell or cells within the same environment but our data also demonstrates the feasibility of achieving dual pharmacology when targeting molecules in very different compartments: a soluble serum protein (PCSK9) and a GPCR predominately expressed in pancreatic -cells (GLP-1R)
Inoue T, Inoguchi T, Sonoda N, Hendarto H, Makimura H, Sasaki S, Yokomizo H, Fujimura Y, Miura D, Takayanagi R